Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

175568

registered interest
date	26/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	IVF
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 22 January (HL4043), why researchers "believe that being able to undertake the techniques in treatment would provide a greater understanding of the way in which mitochondrial DNA mutations are passed down from mother to child" if they are already confident that the risks of mitochondrial disease in the next generation will be low; which researchers have suggested such investigations, as described in paragraph 1.11 of their February 2014 consultation document entitled "Mitochondrial Donation"; how they propose to investigate how mutations vary in each of the different cells of the resulting children; and what additional information the proposed investigations would be expected to provide that was not previously described in <i>Fertility and Sterility</i> in 2003 (Volume 80, Supplement 3, p56).
tabling member printed	Lord Alton of Liverpool
uin	HL4411
answer	answer is ministerial correction date of answer 09/02/2015 answer text <p>Mitochondrial DNA is passed down from mother to child but normal embryonic development can affect how mitochondria are distributed in the different cells and tissues of the body. We are advised that developing mitochondrial donation techniques will help our understanding of this normal phenomenon.</p><p> </p><p><strong> </strong></p><p> </p><p>Paragraph 1.11 of the consultation document on the draft mitochondrial donation regulations was informed by researchers who provided evidence to the Human Fertilisation and Embryology Authority convened Expert Panel that conducted three scientific reviews of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception.</p><p> </p><p><em> </em></p><p> </p><p>We are also advised that the techniques used to investigate how mutations vary in each of the different cells of the resulting children would be identical to those already used to evaluate mitochondrial DNA.</p><p> </p><p> </p><p> </p><p>The research abstract in Fertility and Sterility in 2003 (Volume 80, Supplement 3, p56) does not present experimental details.</p><p> </p> answering member printed Earl Howe question first answered 09/02/2015 16:50:46 answering member 2000 label Biography information for Earl Howe
tabling member	738 label Biography information for Lord Alton of Liverpool

175569

registered interest
date	26/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Liver Diseases
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what steps they are taking to improve care and treatment for patients with hepatic encephalopathy.
tabling member printed	Lord Avebury
uin	HL4412
answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>NHS England, Public Health England (PHE) and the Department of Health are working jointly with stakeholders to make sure that patients with liver disease, including those who may develop hepatic encephalopathy, are supported. PHE is also working with stakeholders to develop a liver disease framework.</p><p> </p><p> </p><p> </p><p>There are currently no plans to carry out a clinical audit into services for people with advanced liver disease for all causes. However, liver cancer outcomes for the specialised services which NHS England commissions are currently audited and a national audit of outcome dimensions for the treatment of hepatitis C will be established by NHS England in due course. In addition, PHE is working with the Lancet Commission on Liver Disease to use routine data to investigate elements of care for people with advanced liver disease.</p><p> </p><p> </p><p> </p><p>We are also taking action to prevent people developing liver disease in the first place by tackling two of the main causes of liver disease – obesity and alcohol misuse. This includes:</p><p> </p><p> </p><p> </p><p>- our Call to Action on Obesity, which sets out two national ambitions for a downward trend in level of excess weight in children and adults by 2020; and</p><p> </p><p> </p><p> </p><p>- our Alcohol Strategy, which aims to cut the number of people drinking above the lower-risk guidelines.</p><p> </p> answering member printed Earl Howe grouped question UIN HL4413 question first answered 03/02/2015 13:55:48 answering member 2000 label Biography information for Earl Howe
tabling member	1665 label Biography information for Lord Avebury

175570

registered interest
date	26/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Liver Diseases
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether they have plans to work with NHS England to ensure that a clinical audit is carried out into services for people with advanced liver disease from all causes.
tabling member printed	Lord Avebury
uin	HL4413
answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>NHS England, Public Health England (PHE) and the Department of Health are working jointly with stakeholders to make sure that patients with liver disease, including those who may develop hepatic encephalopathy, are supported. PHE is also working with stakeholders to develop a liver disease framework.</p><p> </p><p> </p><p> </p><p>There are currently no plans to carry out a clinical audit into services for people with advanced liver disease for all causes. However, liver cancer outcomes for the specialised services which NHS England commissions are currently audited and a national audit of outcome dimensions for the treatment of hepatitis C will be established by NHS England in due course. In addition, PHE is working with the Lancet Commission on Liver Disease to use routine data to investigate elements of care for people with advanced liver disease.</p><p> </p><p> </p><p> </p><p>We are also taking action to prevent people developing liver disease in the first place by tackling two of the main causes of liver disease – obesity and alcohol misuse. This includes:</p><p> </p><p> </p><p> </p><p>- our Call to Action on Obesity, which sets out two national ambitions for a downward trend in level of excess weight in children and adults by 2020; and</p><p> </p><p> </p><p> </p><p>- our Alcohol Strategy, which aims to cut the number of people drinking above the lower-risk guidelines.</p><p> </p> answering member printed Earl Howe grouped question UIN HL4412 question first answered 03/02/2015 13:55:48 answering member 2000 label Biography information for Earl Howe
tabling member	1665 label Biography information for Lord Avebury

175583

registered interest
date	26/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	General Practitioners
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how many single-handed general practitioner practices are operating in (1) England, and (2) London.
tabling member printed	Lord Mawson
uin	HL4426
answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>The latest figures, published by the Health and Social Care Information Centre in September 2013, show that there are 891 single-handed general practitioner (GP) practices in England, representing 11.2% of the total number of GP practices in England.</p><p> </p><p> </p><p> </p><p>There are 1,445 GP practices in London, of which 238 are single-handed GP practices, representing 16.5% of the GP practices in London.</p><p> </p><p> </p><p> </p><p>NHS England is responsible for commissioning primary care services and has advised that there are no plans to close existing small or single-handed practices. The aim is to look at how primary care services can continue to be developed to offer patients better access and more choice.</p><p> </p> answering member printed Earl Howe grouped question UIN HL4427 question first answered 03/02/2015 13:54:42 answering member 2000 label Biography information for Earl Howe
tabling member	3830 label Biography information for Lord Mawson

175584

registered interest
date	26/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	General Practitioners
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what steps they are taking to bring to an end single-handed general practitioner practices in (1) England, and (2) London; and to what timescales they are working.
tabling member printed	Lord Mawson
uin	HL4427
answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>The latest figures, published by the Health and Social Care Information Centre in September 2013, show that there are 891 single-handed general practitioner (GP) practices in England, representing 11.2% of the total number of GP practices in England.</p><p> </p><p> </p><p> </p><p>There are 1,445 GP practices in London, of which 238 are single-handed GP practices, representing 16.5% of the GP practices in London.</p><p> </p><p> </p><p> </p><p>NHS England is responsible for commissioning primary care services and has advised that there are no plans to close existing small or single-handed practices. The aim is to look at how primary care services can continue to be developed to offer patients better access and more choice.</p><p> </p> answering member printed Earl Howe grouped question UIN HL4426 question first answered 03/02/2015 13:54:42 answering member 2000 label Biography information for Earl Howe
tabling member	3830 label Biography information for Lord Mawson

175724

registered interest
date	26/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Conversion Therapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, which organisations (a) were invited to and (b) attended roundtable discussions with him regarding conversion therapy in early March or late April 2014.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	222055
answer	answer is ministerial correction date of answer 02/02/2015 answer text <p>The Department invited the following organisations to a round table event to discuss gay conversion therapy on 2 April 2014:</p><p> </p><p> </p><p> </p><p>Association of Christian Counsellors</p><p> </p><p>British Association for Behavioural and Cognitive Psychotherapies</p><p> </p><p>British Association of Counselling and Psychotherapy</p><p> </p><p>British Psychoanalytic Council</p><p> </p><p>British Psychological Society</p><p> </p><p>Department of Communities and Local Government</p><p> </p><p>General Medical Council</p><p> </p><p>Royal College of General Practitioners</p><p> </p><p>Health and Care Professions Council</p><p> </p><p>National Counselling Society</p><p> </p><p>NHS England</p><p> </p><p>PACE</p><p> </p><p>Pink Therapy</p><p> </p><p>Relate</p><p> </p><p>Royal College of Psychiatrists</p><p> </p><p>Stonewall</p><p> </p><p>UK Council for Psychotherapy</p><p> </p><p> </p><p> </p><p> </p><p>The following organisations were also invited but were unable to attend.</p><p> </p><p> </p><p> </p><p>Inter Faith Network</p><p> </p><p>Professional Standards Authority</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 02/02/2015 15:48:39 answering member 1439 label Biography information for Norman Lamb
tabling member	1533 label Biography information for Dame Diana Johnson

175725

registered interest
date	26/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	IVF
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 26 January 2015 to Questions HL4063 and HL4228, how the Expert Panel convened by the Human Fertilisation and Embryology Authority (HFEA) were assured that the children concerned were genetically normal; whether each of the mitochondrial diseases listed in Annex D of the Department of Health's consultation document Mitochondrial Donation is associated with an abnormal karyotype; and if he will place in the Library a copy of the correspondence between the member of the HFEA's Expert Panel and the Zhang research group.
tabling member constituency	Enfield, Southgate
tabling member printed	Mr David Burrowes
uin	222066
answer	answer is ministerial correction date of answer 29/01/2015 answer text <p>The Human Fertilisation and Embryology Authority (HFEA) has advised that the term ‘genetically normal’ was used in reference to the detail outlined in the Zhang et al abstract regarding the outcome of genetic tests, as follows:</p><p> </p><p> </p><p> </p><p>“Nuclear genetic fingerprinting confirmed that the nuclear DNA from 24 and 29 wk fetuses matched that of the patient’s. Mt DNA profiles in fetal red blood cells were similar to those from cytoplast donor with no detection of patient (karyoplast donor) Mt DNA.“</p><p> </p><p> </p><p> </p><p>We are also advised that all of the mitochondrial diseases listed in the consultation document are due to point mutations or deletions and thus there is a normal karyotype.</p><p> </p><p> </p><p> </p><p>On the question of correspondence between a member of the HFEA convened Expert Panel and the Zhang research group, I have nothing further to add to the information given to Questions <a href="http://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Lords/2015-01-12/HL4063/" target="_blank">HL4063</a> and <a href="http://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Lords/2015-01-16/HL4228/" target="_blank">HL4228</a>.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 29/01/2015 17:23:44 answering member 3918 label Biography information for Jane Ellison
tabling member	1518 label Biography information for Mr David Burrowes

175726

registered interest
date	26/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Private Sector
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what amount of contribution private healthcare providers which are unable to arrange their own insurance make to the Clinical Negligence Scheme for Trusts; and whether that amount is the same as the contributions required of NHS trusts.
tabling member constituency	Birmingham, Hall Green
tabling member printed	Mr Roger Godsiff
uin	222058
answer	answer is ministerial correction date of answer 02/02/2015 answer text <p>It is a requirement of the NHS standard contract, which is mandated by NHS England for use by commissioners for all contracts for healthcare services other than primary care, that providers have appropriate indemnity cover in place. The Department of Health took steps when it amended the Clinical Negligence Scheme regulations in April 2013 to enable independent sector healthcare providers performing NHS contracts to have in place sufficient indemnity cover to meet the cost of clinical claims arising from any negligent treatment by the independent sector provider in the course of providing those NHS services.</p><p> </p><p> </p><p> </p><p>There were two key elements to these changes. Firstly, to allow independent sector providers to become members of the Clinical Negligence Scheme for Trusts (CNST) if they hold a direct contract for relevant health services with a commissioning body, and/or if they subcontract with another body, who is not a member of CNST, which does hold a direct contract for relevant health services with a commissioning body. Secondly, where the organisation holding a direct contract with a commissioning body is a member of CNST, certain of the liabilities of any subcontractors it engages to provide NHS services in relation to that contract are treated and dealt with as though a liability of the member.</p><p> </p><p> </p><p> </p><p>The April 2013 amendment regulations were designed in this way to address the issue of increasingly complex care pathways involving multiple healthcare providers, revising CNST to provide a means of covering the whole potential care pathway within the NHS and enabling main contractors to meet their responsibilities under the NHS standard contract with respect to indemnity for the liabilities of subcontractors. The intention is to provide more positive and timely outcomes for claimants and to improve the sub-contracting carried out by members.</p><p> </p><p> </p><p> </p><p>The costs of CNST are met by membership contributions. The projected claim costs are assessed in advance each year by professional actuaries. Contributions are then calculated to meet the total forecast expenditure for that year. Individual member contribution levels are influenced by a range of factors, including the nature and volume of services provided, the number of ‘whole time equivalent’ clinical staff employed within each service, and claims history. For the independent sector, this last factor is not the reflected in their contributions in the same way as NHS members, because the NHS Litigation Authority does not yet have sufficient information on the claims experience of independent sector providers since they have not been delivering care as members of CNST for long enough.</p><p> </p><p> </p><p> </p><p>Information on the contributions made by all members of CNST, including independent sector members, are published annually by the NHS Litigation Authority on its website, and a copy of the data for 2013-14 is attached to this reply:</p><p> </p><p> </p><p> </p><p><a href="http://www.nhsla.com/Pages/Publications.aspx?library=currentactivity%7cfactsheets%7cfactsheet5trustandhealthauthorityclaimsdata" target="_blank">http://www.nhsla.com/Pages/Publications.aspx?library=currentactivity%7cfactsheets%7cfactsheet5trustandhealthauthorityclaimsdata</a></p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter grouped question UIN 222057 222101 question first answered 02/02/2015 17:42:20 answering member 3932 label Biography information for Dr Dan Poulter attachment 1 file name Contributions by members of CNST 2013-14.xls title Contributions by members of CNST 2013-14
tabling member	304 label Biography information for Mr Roger Godsiff

175727

registered interest
date	26/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Private Sector
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will clarify the steps taken to ensure that private healthcare providers performing NHS contracts hold sufficient indemnity cover to meet all future medical negligence claims and associated legal costs against the NHS arising from negligent treatment by the private provider.
tabling member constituency	Birmingham, Hall Green
tabling member printed	Mr Roger Godsiff
uin	222057
answer	answer is ministerial correction date of answer 02/02/2015 answer text <p>It is a requirement of the NHS standard contract, which is mandated by NHS England for use by commissioners for all contracts for healthcare services other than primary care, that providers have appropriate indemnity cover in place. The Department of Health took steps when it amended the Clinical Negligence Scheme regulations in April 2013 to enable independent sector healthcare providers performing NHS contracts to have in place sufficient indemnity cover to meet the cost of clinical claims arising from any negligent treatment by the independent sector provider in the course of providing those NHS services.</p><p> </p><p> </p><p> </p><p>There were two key elements to these changes. Firstly, to allow independent sector providers to become members of the Clinical Negligence Scheme for Trusts (CNST) if they hold a direct contract for relevant health services with a commissioning body, and/or if they subcontract with another body, who is not a member of CNST, which does hold a direct contract for relevant health services with a commissioning body. Secondly, where the organisation holding a direct contract with a commissioning body is a member of CNST, certain of the liabilities of any subcontractors it engages to provide NHS services in relation to that contract are treated and dealt with as though a liability of the member.</p><p> </p><p> </p><p> </p><p>The April 2013 amendment regulations were designed in this way to address the issue of increasingly complex care pathways involving multiple healthcare providers, revising CNST to provide a means of covering the whole potential care pathway within the NHS and enabling main contractors to meet their responsibilities under the NHS standard contract with respect to indemnity for the liabilities of subcontractors. The intention is to provide more positive and timely outcomes for claimants and to improve the sub-contracting carried out by members.</p><p> </p><p> </p><p> </p><p>The costs of CNST are met by membership contributions. The projected claim costs are assessed in advance each year by professional actuaries. Contributions are then calculated to meet the total forecast expenditure for that year. Individual member contribution levels are influenced by a range of factors, including the nature and volume of services provided, the number of ‘whole time equivalent’ clinical staff employed within each service, and claims history. For the independent sector, this last factor is not the reflected in their contributions in the same way as NHS members, because the NHS Litigation Authority does not yet have sufficient information on the claims experience of independent sector providers since they have not been delivering care as members of CNST for long enough.</p><p> </p><p> </p><p> </p><p>Information on the contributions made by all members of CNST, including independent sector members, are published annually by the NHS Litigation Authority on its website, and a copy of the data for 2013-14 is attached to this reply:</p><p> </p><p> </p><p> </p><p><a href="http://www.nhsla.com/Pages/Publications.aspx?library=currentactivity%7cfactsheets%7cfactsheet5trustandhealthauthorityclaimsdata" target="_blank">http://www.nhsla.com/Pages/Publications.aspx?library=currentactivity%7cfactsheets%7cfactsheet5trustandhealthauthorityclaimsdata</a></p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter grouped question UIN 222058 222101 question first answered 02/02/2015 17:42:20 answering member 3932 label Biography information for Dr Dan Poulter attachment 1 file name Contributions by members of CNST 2013-14.xls title Contributions by members of CNST 2013-14
tabling member	304 label Biography information for Mr Roger Godsiff

175728

registered interest
date	26/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Private Sector
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will require contracts between NHS hospitals and private surgery providers to include a clause preventing the NHS from being sued for libel if it publishes any report investigating damage caused by surgery carried out by the provider.
tabling member constituency	Birmingham, Hall Green
tabling member printed	Mr Roger Godsiff
uin	222100
answer	answer is ministerial correction date of answer 02/02/2015 answer text <p>NHS England publishes the NHS standard contract, which is used by NHS commissioners for all healthcare contracts, other than primary care. The standard contract includes requirements in relation to the approval and management of any subcontracts a provider may wish to put in place. However, NHS England does not mandate the use of a particular form of subcontract.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 02/02/2015 17:42:53 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	304 label Biography information for Mr Roger Godsiff